Sarcoma, Synovial
9 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
Sarcoma, Synovial| Treatment and condition | Where it stands | Trials |
|---|
| Definitive radiotherapy for sarcoma, synovial | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Echocardiography + Biospecimen Collection + Computed Tomography + Multigated Acquisition Scan + Zanzalintinib for sarcoma, synovial | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Letetresgene autoleucel (lete-cel, GSK3377794) + Cyclophosphamide + FLUDARABINE for sarcoma, synovial | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Peptide vaccine IPX for sarcoma, synovial | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Proton beam radiation therapy + Surgical resection for sarcoma, synovial | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Proton beam radiation therapy + Surgical resection + PAZOPANIB + Doxorubicin + Ifosfamide for sarcoma, synovial | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Proton beam radiation therapy + Surgical resection + SELINEXOR + PAZOPANIB + Doxorubicin + Ifosfamide for sarcoma, synovial | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Quality of Life + Functional outcome + preoperative for sarcoma, synovial | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE for sarcoma, synovial | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|